SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alkem Laboratories board declares second interim dividend

09 Mar 2016 Evaluate

Alkem Laboratories has informed that the Board of Directors of the Company at its meeting held on March 09, 2016, has declared second Interim Dividend of Rs 9.7 per equity share on the face value of Rs 2 per share for the financial year 2015-16. The date of payment of Interim Dividend shall be on & from March 23, 2016.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5644.80 -3.15 (-0.06%)
10-Jul-2026 12:11 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1936.75
Dr. Reddys Labs. 1246.20
Cipla 1443.75
Zydus Lifesciences 1155.60
Lupin 2507.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: